Literature DB >> 12039712

Increased fasting plasma ghrelin levels in patients with bulimia nervosa.

Muneki Tanaka1, Tetsuro Naruo, Tetsuro Muranaga, Daisuke Yasuhara, Tomomi Shiiya, Masamitsu Nakazato, Shigeru Matsukura, Shin-Ichi Nozoe.   

Abstract

OBJECTIVE: Fasting plasma ghrelin levels play an important role in the pathophysiology of the eating disorder anorexia nervosa. Bulimia nervosa (BN) also has been associated with abnormal neuroendocrine regulation. Thus, we examined the relationship between body mass index (BMI) and plasma ghrelin concentrations in patients with BN for the first time.
METHODS: The subjects included 15 female BN patients and 11 female healthy volunteers (controls). Fasting blood samples were collected from all subjects.
RESULTS: The plasma ghrelin concentrations in all subjects demonstrated a significantly negative correlation with BMI. Mean plasma ghrelin level in BN patients was significantly higher than that in the controls, though mean BMIs between the groups were not significantly different.
CONCLUSION: These findings suggest that not only BMI but also abnormal eating behaviors with habitual binge eating and purging may have some influence on circulating ghrelin level in BN.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12039712     DOI: 10.1530/eje.0.146r001

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  19 in total

Review 1.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

2.  Stress-induced release of GUT peptides in young women classified as restrained or unrestrained eaters.

Authors:  Esther Hilterscheid; Reinhold Laessle
Journal:  Eat Weight Disord       Date:  2015-03-18       Impact factor: 4.652

3.  Appetite-Related Gut Peptides in Obesity and Binge Eating Disorder.

Authors:  Allan Geliebter; Christopher N Ochner; Roni Aviram-Friedman
Journal:  Am J Lifestyle Med       Date:  2008-07-01

4.  Ghrelin and nicotine stimulate equally the dopamine release in the rat amygdala.

Authors:  Miklós Palotai; Zsolt Bagosi; Miklós Jászberényi; Krisztina Csabafi; Roberta Dochnal; Máté Manczinger; Gyula Telegdy; Gyula Szabó
Journal:  Neurochem Res       Date:  2013-07-09       Impact factor: 3.996

Review 5.  Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy.

Authors:  Sebastian Cardona Cano; Myrte Merkestein; Karolina P Skibicka; Suzanne L Dickson; Roger A H Adan
Journal:  CNS Drugs       Date:  2012-04-01       Impact factor: 5.749

Review 6.  Current and potential roles of ghrelin in clinical practice.

Authors:  G Angelidis; V Valotassiou; P Georgoulias
Journal:  J Endocrinol Invest       Date:  2010-12       Impact factor: 4.256

7.  Glucose-mediated control of ghrelin release from primary cultures of gastric mucosal cells.

Authors:  Ichiro Sakata; Won-Mee Park; Angela K Walker; Paul K Piper; Jen-Chieh Chuang; Sherri Osborne-Lawrence; Jeffrey M Zigman
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-13       Impact factor: 4.310

8.  Ghrelin secretion in severely obese subjects before and after a 3-week integrated body mass reduction program.

Authors:  P S Morpurgo; M Resnik; F Agosti; V Cappiello; A Sartorio; A Spada
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

Review 9.  Ghrelin and eating disorders.

Authors:  Deniz Atalayer; Charlisa Gibson; Alexandra Konopacka; Allan Geliebter
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-08-30       Impact factor: 5.067

10.  Repeated binge access to a palatable food alters feeding behavior, hormone profile, and hindbrain c-Fos responses to a test meal in adult male rats.

Authors:  Nicholas T Bello; Angela S Guarda; Chantelle E Terrillion; Graham W Redgrave; Janelle W Coughlin; Timothy H Moran
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-06-17       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.